Our cohort was recruited from within the
Sickle Cell Ongoing Radiology Evaluation
(SCORE) study funded by the National Institutes
of Health. Our Institution’s review board
approved the protocol of this prospective study
that was also compliant with the Health Insurance
Portability and Accountability Act. Written
informed consent was given by the subjects’
parents with an assent provided by subjects
seven years and older.